InvestorsHub Logo
Followers 0
Posts 127
Boards Moderated 0
Alias Born 04/21/2011

Re: antihama post# 1950

Friday, 11/17/2017 2:06:07 AM

Friday, November 17, 2017 2:06:07 AM

Post# of 3283
"So what do you attribute from the CC this price rise?"

1. as discussed that they broadened the possible application of "exon 20 insertions" in other cancer types. But investors don't know how much meat there is. So any rise based on this is just greed and any investor that buys because of the words of R.S. has no excuse if he gets burned.

2. breakthrough for poziotinib is just around the corner - the market is pricing it in and maybe now or in the future pricing it above the real value ..

3. They mentioned for the first time that they will partner their assets in Japan and Europe - this is one thing the market always reacts on, because of the cash inflow and the prospect that there won't be any dilutions any more (= break even on the horizon is always the strongest price driver in biotech)

4. The IBB / NBI and the overall market is bottening. All other stocks in my portfolio did a good jump, too.

So number 3 and 4 have the greatest weight for me.